Replicate Bioscience, Inc.
San Diego, California, United StatesPurpose
To support the development of a novel self-replicating RNA-based HIV vaccine candidate by advancing preclinical studies of immune-targeted constructs to help accelerate progress toward effective and accessible HIV prevention.
Grantee
Division
Global Health
Date
NOVEMBER 2025
Region served
GLOBAL
Committed amount
$3,573,341
Grant topic
Vaccine Development
Duration (months)
21
Grantee location
San Diego, California, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.